WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'0701 Infant (under 12 months) mortality rate: 452
GDP / capita (US$): 2'2691 Child (under 5 years) mortality rate: 602

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 14'133  13'726  13'331  12'951  12'587  9'862  7'514  5'569 
Births 534  524  513  502  489  396  328  271 
Surviving infants 508  498  487  476  464  370  304  246 
Pop. less than 5 years 2'379  2'313  2'249  2'189  2'130  1'684  1'388  1'087 
Pop. less than 15 years 6'149  5'977  5'809  5'651  5'500  4'449  3'540  2'601 
Female 15-49 years 3'439  3'343  3'248  3'154  3'061  2'299  1'626  1'199 

Number of reported case

(Click for retrospective incidence data for Senegal)
Diphtheria 291 
Japanese encephalitis
Measles 17  46  18  428  999  5'839  5'004  29'144 
Mumps
Pertussis 1'041  22'792 
Polio* 18  138 
Rubella 44  44  141  50  55 
Rubella (CRS)
Tetanus (neonatal) 14  21  12  16  67 
Tetanus (total) 78  118  144  21  16  109  1'378 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Senegal)
Vaccine year result method % card seen                                                
BCG 2012  96  DHS   71  97  94  95  80  97  89  90 
DTP1 2012  96  DHS   71  96  94  80  94  79 
DTP3 2012  89  DHS   71  92  83  83  70  86  52  66 
HepB_BD          81 
HepB3 2012  89  DHS   71  92  83  83  70  86 
Hib3 2012  89  DHS   71  92  83  83  70  86 
JapEnc         
MCV 2012  78  DHS   71  84  82  82  60  79  48  57 
MCV2         
PCV1         
PCV3         
Pol3 2012  83  DHS   71  89  73  73  70  83  49  66 
Rota1         
Rota_last         
Rubella1          84 
TT2plus 2009  57  DHS   66  88  70  60  78  45  37 
PAB         
VAD1          68  60  60  99 
YFV 2012  77  DHS   71  83  82  81  60  71  34 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Senegal)
BCG 97  97  97  97  97  89  90 
DTP1 96  96  97  96  94  79  75 
DTP3 92  91  92  89  86  52  51 
HepB3 92  91  92  89  86 
HepB_BD
Hib3 92  91  92  89  86 
MCV 84  83  84  81  79  48  51 
MCV2
PAB 91  91  88  88  88  62  45 
PCV3
Pol3 89  83  89  79  83  49  53 
Rota_last
YFV 83  80  84  80  76  34 

Number of districts in the country 76  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
90 
   
/
|
|
\
Greater or equal to 90% 21
From 80 to 89% 11
From 50 to 79% 43
Less than 50% 18
Proportion of districts
not reporting DTP3 coverage
7
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
MR 9 months; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Td st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6-11, 12-59 months; Yes and lacting women
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   2013-2017  2012-2016  2007-2011  2007 - 2011  2007 - 2011  2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number 76  76  75  65  65  65  63 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No       

System performance

Total Nº districts in country number 76  76  75  65  65  65  63 
Nº districts with DTP3 coverage >=80% number 24  46  44  16 
% of districts with DTP3 coverage >=80% From 0 to 100% 32  71  68  25 
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100% 11       

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 27  27  32  100  17  100  31 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.